larotrectinib 20 MG (as 24.6 MG larotrectinib sulfate) per 1 ML Oral Solution

RxCUI: 2105649
RxNorm name: larotrectinib 20 MG (as 24.6 MG larotrectinib sulfate) per 1 ML Oral Solution
Display name: larotrectinib 20 MG (as 24.6 MG larotrectinib sulfate) per 1 ML Oral Solution
Full name: larotrectinib 20 MG (as 24.6 MG larotrectinib sulfate) per 1 ML Oral Solution
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VITRAKVI	LAROTRECTINIB	Bayer HealthCare Pharmaceuticals Inc.	0c8ca614-58b2-4aa4-83d3-0387a8f782fd	2026-05-22	Warnings, Adverse reactions	Exact identifier rxcui: 2105649
VITRAKVI	LAROTRECTINIB	Loxo Oncology, Inc.	9525f887-a055-4e33-8e92-898d42828cd1	2018-12-05	Warnings, Adverse reactions	Exact identifier rxcui: 2105649

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
0c8ca614-58b2-4aa4-83d3-0387a8f782fd	larotrectinib 20 MG (as 24.6 MG larotrectinib sulfate) per 1 ML Oral Solution	SY	21	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20260522
0c8ca614-58b2-4aa4-83d3-0387a8f782fd	larotrectinib 20 MG in 1 mL Oral Solution	PSN	21	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20260522
0c8ca614-58b2-4aa4-83d3-0387a8f782fd	larotrectinib 20 MG/ML Oral Solution	SCD	21	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20260522
0c8ca614-58b2-4aa4-83d3-0387a8f782fd	larotrectinib 20 MG per 1 ML Oral Solution	SY	21	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20260522
9525f887-a055-4e33-8e92-898d42828cd1	larotrectinib 20 MG/ML Oral Solution	SCD	3	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20181205
9525f887-a055-4e33-8e92-898d42828cd1	larotrectinib 20 MG in 1 mL Oral Solution	PSN	3	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20181205
9525f887-a055-4e33-8e92-898d42828cd1	larotrectinib 20 MG per 1 ML Oral Solution	SY	3	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20181205
9525f887-a055-4e33-8e92-898d42828cd1	larotrectinib 20 MG (as 24.6 MG larotrectinib sulfate) per 1 ML Oral Solution	SY	3	These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018	20181205